@WSJ pharma reporter, @Bagehots fellow '25-26. Signal: ajanin.777

New York, NY
Joined March 2013
A wild October surprise. w/ @LizzyLaw_
6
3
1
10
1,228
EXCLUSIVE - Top RFK Jr. ally and adviser Calley Means has quit the Trump administration. Means was frustrated by White House delays of some of Kennedy’s popular food policies and blamed others in the administration for allowing food companies and special interests to have too much sway, people familiar with the matter said. One of them described him as “disillusioned.” wsj.com/politics/policy/call…
62
187
37
693
210,847
Alex Janin retweeted
NEW: I dug into a new class of drugs called "protein degraders" that pharma companies are pouring billions of dollars into, hoping to find a new tool to attack diseases from cancer to Parkinson’s. wsj.com/health/pharma/big-ph…
4
20
1,064
Alex Janin retweeted
"Gifts, payments, free meals, and other marketing ploys by pharmaceutical companies heavily influence doctors to prescribe more drugs, choose less appropriate treatments, and drive up prescription costs, according to a systematic review of 93 studies." usrtk.org/healthwire/drug-co…
4
14
3
21
2,572
Alex Janin retweeted
Crazy WSJ data. Between 2022 and 2025, wealth increased 37% for Americans 75 and older, while **decreased** 23% for people under 35. wsj.com/economy/affluent-and…
129
946
150
4,178
425,224
Alex Janin retweeted
Context for this HHS inquiry ⬇️ “Kennedy, who for many years worked as an environmental lawyer, successfully petitioned a federal court in 2020 to force the Federal Communications Commission to review its wireless-radiation rules.” wsj.com/health/rfk-jr-s-heal…
What should we know about wireless exposure? HHS is seeking public input and scientific evidence on electromagnetic fields, radiofrequency radiation, and potential health effects — including questions about 5G, Wi-Fi, and wireless infrastructure. Share your input through our Request for Information (RFI) by October 21: regulations.gov/commenton/HH…
2
3
1
8
3,100
Alex Janin retweeted
$LLY $NVO $HIMS 🚨 BREAKING: ELI LILLY $LLY SUES 5 MORE COMPANIES FOR MAKING COPYCAT RETATRUTIDE - American Peptides LLC - LiveWell Peptides - Cenexa Labs LLC - Medrein Health & Aesthetics - Medshape Weight Loss Clinic LLC This follows 6 lawsuits Lilly filed in August against peptide companies
14
16
7
183
79,291
Alex Janin retweeted
Annual prevalence of GLP-1 RA prescriptions without documentation of a US FDA-approved indication. onlinelibrary.wiley.com/doi/…
6
2
37
4,907
Alex Janin retweeted
Tennessee's failed execution of Christa Pike has resulted in fresh scrutiny of the shaky and secretive supply chain for lethal injection drugs. W/ @AlexLJanin: wsj.com/health/pharma/botche…
5
7
1,588
Alex Janin retweeted
NEW with @LizzyLaw_: The Trump administration is rolling out a program aimed at getting Medicare to match drug prices in other countries for certain high-cost drugs Pharma companies that cut deals with the admin expected to be exempt wsj.com/health/pharma/trump-…
5
1
6
1,634
Hello from the MAHA Summit. A number of reporters denied credentials despite empty press seats. A security guard first said he needed to escort me everywhere but now has given up I guess.
10
47
4
196
19,037
The Danish drugmaker signed a licensing deal for a weight-loss treatment being developed by Hengrui Pharma that could be worth up to $2.6 billion. on.wsj.com/3VgSztO
9
18
2
61
85,422
SCOOP: OpenAI, Anthropic and security researchers are investigating tens of thousands of incidents - not dozens - in which their frontier models took steps that outside evaluators would consider problematic, sources told Axios. The sheer volume of incidents found in our reporting indicate that the problem is orders of magnitude more complex than what is currently publicly known and disclosed. The findings also raise questions about what level of control anyone working on AI development can expect to have over their own technology, and whether these kinds of incidents are becoming synonymous with frontier deployment. Read my latest for Axios here: axios.com/2026/09/26/openai-…
516
1,989
691
6,808
3,918,866
Sen. Kaine (D., Va.) reads our story and asks FDA nominee if she's aware of the plan to revisit the 2021 rule on tobacco applications. Dr. Heidi Overton says she's not involved in the plans and the administration's goal is to protect kids. wsj.com/politics/policy/u-s-…
1
2
5
955
The results for enicepatide reinforce the company’s ambitions to rapidly develop its portfolio of medicines for people with obesity, diabetes and cardiovascular disease. on.wsj.com/4xz7exF
11
3
21
55,341
Replying to @Roche
@Roche notches impressive P2 data for the GLP-1R-GIPR co-co-agonist Enicepatide #T2D #weightloss roche.com/media/releases/med…
2
17
1
90
6,426